These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid. Ohkawa J; Yuyama N; Taira K Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797 [TBL] [Abstract][Full Text] [Related]
27. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection. Tang J; Breaker RR RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650 [TBL] [Abstract][Full Text] [Related]
28. Ribozyme structures and mechanisms. Doherty EA; Doudna JA Annu Rev Biochem; 2000; 69():597-615. PubMed ID: 10966470 [TBL] [Abstract][Full Text] [Related]
29. Group I Intron-Based Therapeutics Through Trans-Splicing Reaction. Lee CH; Han SR; Lee SW Prog Mol Biol Transl Sci; 2018; 159():79-100. PubMed ID: 30340790 [TBL] [Abstract][Full Text] [Related]
30. Enhanced folding of hairpin ribozymes with replaced domains. Komatsu Y; Kanzaki I; Ohtsuka E Biochemistry; 1996 Jul; 35(30):9815-20. PubMed ID: 8703955 [TBL] [Abstract][Full Text] [Related]
32. Group I intron ribozymes. Nielsen H Methods Mol Biol; 2012; 848():73-89. PubMed ID: 22315064 [TBL] [Abstract][Full Text] [Related]
33. Construction of a ribozyme-expression system that effectively transports ribozymes to the cytoplasm. Sano M; Kuwabara T; Nara Y; Warashina M; Taira K Nucleic Acids Symp Ser; 2000; (44):203-4. PubMed ID: 12903339 [TBL] [Abstract][Full Text] [Related]
34. Cis and trans reactions of hairpin ribozymes derived from the negative strand of arabis mosaic virus satellite RNA. Tomita R; Morikawa Y; Hisamatsu S; Suzuki-Fujita K; Tanaka T; Sonoki S; Kikuchi Y Nucleic Acids Symp Ser; 1995; (34):117-8. PubMed ID: 8841580 [TBL] [Abstract][Full Text] [Related]
35. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP. Koizumi M; Soukup GA; Kerr JN; Breaker RR Nat Struct Biol; 1999 Nov; 6(11):1062-71. PubMed ID: 10542100 [TBL] [Abstract][Full Text] [Related]
37. Ribozyme: a clinical tool. Khan AU Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595 [TBL] [Abstract][Full Text] [Related]
38. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target. Li YL; Torchet C; Vergne J; Maurel MC Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868 [TBL] [Abstract][Full Text] [Related]
39. Group II intron ribozymes that cleave DNA and RNA linkages with similar efficiency, and lack contacts with substrate 2'-hydroxyl groups. Griffin EA; Qin Z; Michels WJ; Pyle AM Chem Biol; 1995 Nov; 2(11):761-70. PubMed ID: 9383483 [TBL] [Abstract][Full Text] [Related]
40. Catalytic strategies of the hepatitis delta virus ribozymes. Shih IH; Been MD Annu Rev Biochem; 2002; 71():887-917. PubMed ID: 12045114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]